Jove
Visualize
Contact Us

Related Concept Videos

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

14.4K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
14.4K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.7K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
Mitochondrial Membranes01:45

Mitochondrial Membranes

11.5K
A single mitochondrion is a bean-shaped organelle enclosed by a double-membrane system. The outer membrane of mitochondria is smooth and contains many porins - the integral membrane transporters. Porins enable free diffusion of ions and small uncharged molecules through the outer mitochondrial membrane but limit the transport of molecules larger than 5000 Daltons. Further, the outer mitochondrial membrane forms a unique structure called membrane contact sites with other subcellular organelles,...
11.5K
Mitochondria01:37

Mitochondria

13.7K
Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
13.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A dynamic prognostic model for Polycythemia Vera long-terms outcomes in patients treated with Ruxolitinib.

Blood advances·2026
Same author

Targeting BCL-xL in Myeloid Malignancies: From Inhibitors to PROTAC.

Journal of cellular and molecular medicine·2026
Same author

Clonal Dynamics of FLT3-ITD from Diagnosis to Relapse: Ultra-Sensitive Patient-Specific Monitoring by ddPCR.

International journal of molecular sciences·2026
Same author

Genomic profiling for decision-making in post-polycythemia vera and post-essential thrombocythemia myelofibrosis.

Blood·2026
Same author

Impact of fitness categorization according to SIE/SIES/GITMO criteria in therapy-related and AML-MRC receiving CPX-351.

Blood advances·2026
Same author

Ultra-Sensitive Mutation Detection Technology in Myeloid Neoplasms: New Tools for Patient Monitoring.

Journal of clinical medicine·2026
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jul 16, 2025

Author Spotlight: Transmitochondrial Cybrid Generation Using Cancer Cell Lines
07:49

Author Spotlight: Transmitochondrial Cybrid Generation Using Cancer Cell Lines

Published on: March 17, 2023

2.4K

A Leukemic Target with a Thousand Faces: The Mitochondria.

Beatrice Maffeo1, Cristina Panuzzo1, Amedeo Moraca1

  • 1Department of Clinical and Biological Sciences, University of Turin, 10043 Orbassano, Italy.

International Journal of Molecular Sciences
|September 9, 2023
PubMed
Summary

Acute myeloid leukemia (AML) survival remains low due to clone heterogeneity and resistant leukemic stem cells (LSCs). Targeting metabolic pathways, including with Venetoclax, offers new combination therapy strategies for AML treatment.

Keywords:
AMLAML blastsAML–LSCVenetoclaxmetabolismmitochondriapersonalized therapies

More Related Videos

An Automated Differential Nuclear Staining Assay for Accurate Determination of Mitocan Cytotoxicity
07:58

An Automated Differential Nuclear Staining Assay for Accurate Determination of Mitocan Cytotoxicity

Published on: May 12, 2020

6.9K
Assessment of the Metabolic Profile of Primary Leukemia Cells
06:21

Assessment of the Metabolic Profile of Primary Leukemia Cells

Published on: November 21, 2018

10.5K

Related Experiment Videos

Last Updated: Jul 16, 2025

Author Spotlight: Transmitochondrial Cybrid Generation Using Cancer Cell Lines
07:49

Author Spotlight: Transmitochondrial Cybrid Generation Using Cancer Cell Lines

Published on: March 17, 2023

2.4K
An Automated Differential Nuclear Staining Assay for Accurate Determination of Mitocan Cytotoxicity
07:58

An Automated Differential Nuclear Staining Assay for Accurate Determination of Mitocan Cytotoxicity

Published on: May 12, 2020

6.9K
Assessment of the Metabolic Profile of Primary Leukemia Cells
06:21

Assessment of the Metabolic Profile of Primary Leukemia Cells

Published on: November 21, 2018

10.5K

Area of Science:

  • Hematology
  • Cancer Biology
  • Metabolic Pathways

Background:

  • Acute myeloid leukemia (AML) exhibits significant heterogeneity, contributing to poor patient survival rates.
  • Chemotherapy resistance and disease relapse are driven by diverse AML clones and persistent leukemic stem cells (LSCs).
  • Leukemic stem cells possess distinct metabolic profiles compared to AML blasts, enabling their survival and disease recurrence.

Purpose of the Study:

  • To review metabolic differences between AML blasts and LSCs.
  • To identify druggable molecular pathways in mitochondria and metabolism for leukemia therapy.
  • To highlight the potential of combination therapies, including metabolism inhibitors, for improving AML treatment efficacy.

Main Methods:

  • Literature review of metabolic pathways in AML.
  • Analysis of molecular targets related to mitochondria and cellular metabolism.
  • Evaluation of existing and novel therapeutic strategies for AML.

Main Results:

  • AML blasts and LSCs display distinct metabolic vulnerabilities.
  • Mitochondrial and metabolic pathways represent promising therapeutic targets in AML.
  • Venetoclax has shown significant efficacy in specific AML subtypes, particularly in patients unfit for intensive regimens.

Conclusions:

  • Targeting metabolic pathways offers a promising strategy to overcome AML chemoresistance and relapse.
  • Combination therapies incorporating metabolism inhibitors could enhance treatment outcomes.
  • Further research into LSC metabolism is crucial for developing more effective AML therapies.